FDA Approves Unknown Drug — ACTAVIS ELIZABETH
Actavis Elizabeth received final FDA approval on February 6, 2004, for the generic drug referenced in ANDA076636; the filing is expected to trigger market interest as the company eyes established competitors within the therapeutic class.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed